Data showed 50% or more of patients reporting >50% improvement in key pain and function scales No adverse events related to dose-limiting ...
As power density soars, air and single-phase loops hit their limits. A new webinar from Advanced Cooling technologies (ACT) shows how loop thermosyphons and pumped two-phase cooling unlock higher ...
In the EMPOWER trials, emraclidine was well-tolerated with a safety profile comparable to that observed in the Phase 1b trial. The most commonly reported adverse events in EMPOWER-1 and EMPOWER-2, ...
Monolithic boost converters can convert low input voltages to a higher output voltage, all in a compact solution size. However, when the output power requirements increase, so do current levels and ...
As biomarker studies employ increasingly complex and expensive genomics and other correlative methods, it is increasingly important to rigorously design these studies and analyze the downstream ...
Amgen said it has started two critical late-stage trials for its experimental weight loss injection, MariTide, another step in its bid to enter the booming obesity drug market. MariTide is a monthly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results